Literature DB >> 8550072

High-level IL-10 production by monoclonal antibody-stimulated human T cells.

M Schwarz1, O Majdic, W Knapp, W Holter.   

Abstract

We investigated interleukin-10 (IL-10) production in freshly isolated mononuclear cells and purified T cells in response to stimulation with monoclonal antibodies (mAb) recognizing CD3, CD2 and CD28, or with the bacterial products Staphylococcus aureus cells (SAC), staphylococcal enterotoxin (SEA) and lipopolysaccharide (LPS). IL-10 production was compared with that of IL-2, IL-4 and interferon-gamma (IFN-gamma). Similar to the other cytokines, in peripheral blood mononuclear cells (PBMC) from adult donors the highest IL-10 levels were produced in response to CD2 plus CD28 stimulation, within 72-96 hr of stimulation. Levels of IL-10 in response to CD2 plus CD28 stimulation (1.9 +/- 1 ng/ml) exceeded those in response to SEA (0.25 +/- 0.16 ng/ml), SAC (0.43 +/- 0.42 ng/ml), or LPS (0.19 +/- 0.14 ng/ml) stimulation. With adult purified T cells, high levels of IL-10 and IL-4 were measured following CD3 plus CD28 stimulation, and the amounts of both T-helper type-2 (Th2) cytokines decreased following the addition of phorbol myristate acetate (PMA), whereas the synthesis of the Th1 cytokines IL-2 and IFN-gamma was enhanced. When PBMC were stimulated with a CD3 mAb and different other cytokines were added, strong enhancement of IL-10 production was seen upon the addition of IL-2, IL-4, IL-7, IL-12 and IFN-gamma, whereas inhibition was found with transforming growth factor-beta 1 (TGF-beta 1). These data illustrate that in freshly isolated PBMC large amounts of IL-10 can be induced rapidly by appropriate mAb stimulation, and that even in freshly isolated cells IL-4 and IL-10 show signs of parallel regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8550072      PMCID: PMC1383938     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation.

Authors:  J Krutmann; R Kirnbauer; A Köck; T Schwarz; E Schöpf; L T May; P B Sehgal; T A Luger
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

2.  Transforming growth factor-beta inhibits IL-4 and IFN-gamma production by stimulated human T cells.

Authors:  W Holter; F S Kalthoff; W F Pickl; C Ebner; O Majdic; D Kraft; W Knapp
Journal:  Int Immunol       Date:  1994-03       Impact factor: 4.823

3.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

4.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

5.  Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.

Authors:  J R Ortaldo; A T Mason; J J O'Shea; M J Smyth; L A Falk; I C Kennedy; D L Longo; F W Ruscetti
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

6.  Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production.

Authors:  T Van der Pouw-Kraan; C Van Kooten; I Rensink; L Aarden
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

7.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

8.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

9.  Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory.

Authors:  S Ehlers; K A Smith
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  5 in total

1.  Influence of costimulatory molecules on immune response to Leishmania major by human cells in vitro.

Authors:  C I Brodskyn; G K DeKrey; R G Titus
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  T cells of the human intestinal lamina propria are high producers of interleukin-10.

Authors:  J Braunstein; L Qiao; F Autschbach; G Schürmann; S Meuer
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

3.  T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC).

Authors:  J O'Keeffe; K Mills; J Jackson; C Feighery
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

4.  Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Authors:  M-A Jenabian; M Patel; I Kema; K Vyboh; C Kanagaratham; D Radzioch; P Thébault; R Lapointe; N Gilmore; P Ancuta; C Tremblay; J-P Routy
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

5.  CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice.

Authors:  Jocelyn C Pérez-Lara; Enrique Espinosa; Leopoldo Santos-Argumedo; Héctor Romero-Ramírez; Gabriela López-Herrera; Fabio García-García; Claudia Sandoval-Montes; Vianney Ortiz-Navarrete; Mónica Flores-Muñoz; Juan C Rodríguez-Alba
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.